Cargando…
Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease
BACKGROUND: While Alzheimer disease (AD) is generally considered as a brain disorder, blood biomarkers may be useful for the diagnosis and prediction of AD brain pathology. The APOE ε4 allele has shown cerebrovascular effects including acceleration of blood-brain barrier (BBB) breakdown. METHODS: We...
Autores principales: | Panitch, Rebecca, Hu, Junming, Xia, Weiming, Bennett, David A., Stein, Thor D., Farrer, Lindsay A., Jun, Gyungah R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830081/ https://www.ncbi.nlm.nih.gov/pubmed/35139885 http://dx.doi.org/10.1186/s13195-022-00975-z |
Ejemplares similares
-
Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease
por: Panitch, Rebecca, et al.
Publicado: (2021) -
Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease
por: Jun, Gyungah R., et al.
Publicado: (2022) -
APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry
por: Belloy, Michael E., et al.
Publicado: (2023) -
APOE genotype and Alzheimer’s immunotherapy
por: Pankiewicz, Joanna E., et al.
Publicado: (2017) -
Association of APOE Genotypes and Chronic Traumatic Encephalopathy
por: Atherton, Kathryn, et al.
Publicado: (2022)